WALD
Waldencast plc
$0.88
+0.00
(+0.00%)
Mkt Cap
104.98M
Volume
277,019
52W Range
0.71-3.22
Sector
Consumer Defensive
Beta
-0.04
EPS (TTM)
-2.01 USD
P/E Ratio
-0.94
Revenue (TTM)
272.07M USD
Rev Growth (5Y)
+23.6%
EPS Growth (5Y)
N/A
Company Description
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti on December 8, 2020 and is headquartered in White Plains, NY.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | 272.07M | 273.87M | 218.14M | 166.13M | 142.47M | 94.43M |
| Net Income | (229.75M) | (42.44M) | (89.98M) | (116.62M) | (19.58M) | (2.37M) |
| EPS | -2.01 | -0.39 | -0.89 | -1.08 | -0.45 | -0.20 |
| Free Cash Flow | (16.25M) | (11.83M) | (31.82M) | (87.51M) | 2.24M | (9.14M) |
| FCF / Share | -0.14 | -0.11 | -0.31 | -0.81 | 0.05 | -0.78 |
| Operating CF | (12.82M) | (8.82M) | (29.77M) | (85.01M) | 3.53M | (7.43M) |
| Total Assets | 816.20M | 975.86M | 1.04B | 1.09B | 184.59M | 166,792 |
| Total Debt | 149.01M | 182.11M | 177.72M | 199.25M | 118.86M | 0 |
| Cash & Equiv | 31.89M | 14.80M | 22.58M | 8.69M | 12.79M | 0 |
| Book Value | 461.88M | 662.32M | 624.63M | 639.24M | 39.24M | (10,951) |
| Return on Equity | -0.50 | -0.06 | -0.14 | -0.18 | -0.50 | N/A |
| Metric | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.10M | 139.80M | 132.27M | 142.29M | 131.58M | 108.80M | 109.34M | 89.85M | 76.28M | 71.24M | 71.24M | 47.21M |
| Net Income | (106.33M) | (60.31M) | (169.44M) | (32.37M) | (10.07M) | (78.21M) | (11.77M) | (107.15M) | (9.47M) | (9.79M) | (9.79M) | (1.19M) |
| EPS | -0.90 | -0.51 | -1.51 | -0.29 | -0.09 | -0.64 | -0.11 | -1.00 | -0.08 | -0.23 | -0.23 | -0.10 |
| Free Cash Flow | (10.10M) | (2.15M) | (14.10M) | 1.14M | (12.67M) | (13.86M) | (17.51M) | (43.76M) | (43.76M) | 352,628 | 1.12M | (4.57M) |
| FCF / Share | -0.09 | -0.02 | -0.13 | 0.01 | -0.11 | -0.11 | -0.16 | -0.41 | -0.41 | 0.01 | 0.03 | -0.39 |
| Operating CF | (10.10M) | (1.29M) | (11.53M) | 2.56M | (11.38M) | (13.41M) | (16.36M) | (42.51M) | (42.51M) | 352,628 | 1.76M | (3.72M) |
| Total Assets | 646.73M | 816.20M | 797.75M | 975.86M | 1.01B | 1.04B | 1.09B | 1.09B | N/A | 184.59M | 346.30M | 200,731 |
| Total Debt | 149.31M | 149.01M | 193.08M | 182.11M | 188.49M | 177.72M | 229.93M | 199.25M | N/A | 118.86M | 0 | 0 |
| Cash & Equiv | 7.82M | 31.89M | 10.48M | 14.80M | 19.69M | 22.58M | 18.90M | 8.69M | N/A | 12.79M | 851,860 | 0 |
| Book Value | 391.22M | 461.88M | 499.14M | 662.32M | 618.61M | 624.63M | 615.28M | 639.24M | N/A | 39.24M | 301.88M | 14,049 |
| Return on Equity | -0.27 | -0.13 | -0.34 | -0.05 | -0.02 | -0.13 | -0.02 | -0.17 | N/A | -0.25 | -0.03 | -84.35 |
WALD News
Waldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange Act
Waldencast plc Announces First Half 2026 Financial Results
Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Waldencast Announces Sale of Obagi Medical to Bridgepoint
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*